|
|
| |
| |
Your access to vital information on hematologic cancers is now easier, with comprehensive coverage of this topic at your fingertips. ASCO has gathered and synthesized data on hematologic cancers from a multitude of key sources, including the Journal of Clinical Oncology and other ASCO publications, the Virtual Meeting, and more. Experience the ease of finding in-depth information on hematologic cancers topics, and visit often to remain current with timely updates.
|
|
| |
|
JCO Highlighted Hematologic Cancers Articles
|
Last Updated: January 25, 2010
|
 |
|
Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
(JCO, November 2009)
|
|
|
Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
(JCO, November 2009)
|
|
|
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
(JCO, November 2009)
|
|
|
Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study
(JCO, November 2009)
|
|
|
Phase II Study of Alemtuzumab in Combination With Pentostatin in Patients With T-Cell Neoplasms
(JCO, November 2009)
|
|
|
|
|
Medline Latest Hematologic Cancers Articles
|
Last Updated: March 14, 2010
|
|
|
Circulating serum free light chains as predictive markers of AIDS-related lymphoma.
(J Clin Oncol, 2010 Feb)
|
|
|
Investigational immunotherapeutics for B-cell malignancies.
(J Clin Oncol, 2010 Feb)
|
|
|
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.
(J Clin Oncol, 2010 Feb)
|
|
|
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.
(J Clin Oncol, 2010 Feb)
|
|
|
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia.
(J Clin Oncol, 2010 Feb)
|
|
|
|
|
Virtual Meeting
|
|
|
View hematologic cancers track presentations from the 2008 ASCO Annual Meeting. In addition, search hematologic cancers track presentations from previous meetings.
|
Oral presentations and discussions from the 2005 Annual Meeting
|
|
|
|
Abstracts
|
|
|
Search the 2008 hematologic cancers abstracts as well as abstracts back through the 2000 Annual Meeting.
|
Abstract presented at 2005 Annual Meeting
|
|
|
|
Educational Book
|
|
|
Find hematologic cancers manuscripts grouped into areas of interest, or search the 2002-2009 Educational Books archive.
|
|
|
|
Cancer.Net
|
|
|
Find information and resources to support your patients living with hematologic cancers
|
|
|
|
|
|
|
|
 |
|
2010 ASCO Annual Meeting
McCormick Place – Chicago, IL
June 4 - 8, 2010
|
|
This online resource is supported by:
|
|
|
|
|
|
